© 2019 IPHARMA

  • Facebook Social Icon
  • LinkedIn Social Icon
  • YouTube Social  Icon
  • Instagram Social Icon


On September 12, 2016, IPHARMA was authorized by the Ministry of Health of the Russian Federation to conduct the Phase IIa clinical trial of the medicinal product VM-1011.

Protocol № HBV-VM1011-02 "A partially-blind randomized comparative pilot clinic...

Please reload

Please reload

Поиск по тегам